211 related articles for article (PubMed ID: 23014529)
1. TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.
Matsushima-Miyagi T; Hatano K; Nomura M; Li-Wen L; Nishikawa T; Saga K; Shimbo T; Kaneda Y
Clin Cancer Res; 2012 Nov; 18(22):6271-83. PubMed ID: 23014529
[TBL] [Abstract][Full Text] [Related]
2. Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.
Kawaguchi Y; Miyamoto Y; Inoue T; Kaneda Y
Int J Cancer; 2009 May; 124(10):2478-87. PubMed ID: 19173282
[TBL] [Abstract][Full Text] [Related]
3. An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis.
Liu LW; Nishikawa T; Kaneda Y
Mol Ther; 2016 Feb; 24(1):135-45. PubMed ID: 26548591
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus.
Gao H; Gong XC; Chen ZD; Xu XS; Zhang Q; Xu XM
Biomed Environ Sci; 2014 Jul; 27(7):506-14. PubMed ID: 25073909
[TBL] [Abstract][Full Text] [Related]
5. The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis.
Kaneda Y
Oncoimmunology; 2013 Apr; 2(4):e23566. PubMed ID: 23734313
[TBL] [Abstract][Full Text] [Related]
6. Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells.
Qian M; Tan HM; Yu N; Wang T; Zhang Q
Biomed Environ Sci; 2018 Apr; 31(4):280-289. PubMed ID: 29773091
[TBL] [Abstract][Full Text] [Related]
7. Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.
Kurooka M; Kaneda Y
Cancer Res; 2007 Jan; 67(1):227-36. PubMed ID: 17210703
[TBL] [Abstract][Full Text] [Related]
8. Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells.
Li S; Nishikawa T; Kaneda Y
Cancer Sci; 2017 Dec; 108(12):2333-2341. PubMed ID: 28945328
[TBL] [Abstract][Full Text] [Related]
9. Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.
Matsuda M; Yamamoto T; Matsumura A; Kaneda Y
Gene Ther; 2009 Dec; 16(12):1465-76. PubMed ID: 19675593
[TBL] [Abstract][Full Text] [Related]
10. Negative regulation of RIG-I-mediated antiviral signaling by TRK-fused gene (TFG) protein.
Lee NR; Shin HB; Kim HI; Choi MS; Inn KS
Biochem Biophys Res Commun; 2013 Jul; 437(1):168-72. PubMed ID: 23810392
[TBL] [Abstract][Full Text] [Related]
11. Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation.
Wang Y; Tong X; Ye X
J Immunol; 2012 Dec; 189(11):5304-13. PubMed ID: 23087404
[TBL] [Abstract][Full Text] [Related]
12. IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus.
Zhang Q; Xu X; Yuan Y; Gong X; Chen Z; Xu X
Int J Cancer; 2014 Jan; 134(1):224-34. PubMed ID: 23784981
[TBL] [Abstract][Full Text] [Related]
13. RIG-I Mediates an Antiviral Response to Crimean-Congo Hemorrhagic Fever Virus.
Spengler JR; Patel JR; Chakrabarti AK; Zivcec M; García-Sastre A; Spiropoulou CF; Bergeron É
J Virol; 2015 Oct; 89(20):10219-29. PubMed ID: 26223644
[TBL] [Abstract][Full Text] [Related]
14. DDX3 directly regulates TRAF3 ubiquitination and acts as a scaffold to co-ordinate assembly of signalling complexes downstream from MAVS.
Gu L; Fullam A; McCormack N; Höhn Y; Schröder M
Biochem J; 2017 Feb; 474(4):571-587. PubMed ID: 27980081
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytic Choriomeningitis Virus Differentially Affects the Virus-Induced Type I Interferon Response and Mitochondrial Apoptosis Mediated by RIG-I/MAVS.
Pythoud C; Rothenberger S; Martínez-Sobrido L; de la Torre JC; Kunz S
J Virol; 2015 Jun; 89(12):6240-50. PubMed ID: 25833049
[TBL] [Abstract][Full Text] [Related]
16. Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon.
Tanaka M; Shimbo T; Kikuchi Y; Matsuda M; Kaneda Y
Int J Cancer; 2010 Apr; 126(8):1982-1991. PubMed ID: 19830690
[TBL] [Abstract][Full Text] [Related]
17. Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.
Sugii N; Matsuda M; Okumura G; Shibuya A; Ishikawa E; Kaneda Y; Matsumura A
Cancer Sci; 2021 Jan; 112(1):81-90. PubMed ID: 33155337
[TBL] [Abstract][Full Text] [Related]
18. Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression.
Zhang Q; Yuan WF; Zhai GQ; Zhu SY; Xue ZF; Zhu HF; Xu XM
Biomed Environ Sci; 2012 Oct; 25(5):509-16. PubMed ID: 23122307
[TBL] [Abstract][Full Text] [Related]
19. [Anticancer immunotherapy using inactivated Sendai virus particles].
Kurooka M; Kaneda Y
Uirusu; 2007 Jun; 57(1):19-27. PubMed ID: 18040151
[TBL] [Abstract][Full Text] [Related]
20. Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.
Fujita K; Nakai Y; Kawashima A; Ujike T; Nagahara A; Nakajima T; Inoue T; Lee CM; Uemura M; Miyagawa Y; Kaneda Y; Nonomura N
Cancer Gene Ther; 2017 Jul; 24(7):277-281. PubMed ID: 28497777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
